Concepedia

Eugenie Kleinerman

EK

18

Publications

928

Citations

15

H-Index

1984

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Cleveland Clinic

Eugenie Kleinerman is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

1984–2016

18

Publications

18

Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration.

Eugenie Kleinerman, Shu Jia, Jessica Griffin et al. · Journal of Clinical Oncology · 1992 · 156 citations

The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice

E S Rennel, Elizabeth Waine, Hui Guan et al. · British Journal of Cancer · 2008 · 126 citations · Full text

Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients.

James L. Murray, Eugenie Kleinerman, Joan E. Cunningham et al. · Journal of Clinical Oncology · 1989 · 108 citations

, , +12

Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.

Isaiah J. Fidler, William E. Fogler, Eugenie Kleinerman et al. · The Journal of Immunology · 1985 · 94 citations · Full text

, , +18

Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells.

Elizabeth A. Lafleur, Shu Jia, Laura L. Worth et al. · PubMed · 2001 · 62 citations

, , +18

Rows per page

1–5 of 18